Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 4,454,000 | 3,978,000 | 3,870,000 | 4,357,000 | 4,468,000 |
| Cost of Goods | 2,406,000 | 2,126,000 | 2,107,000 | 2,294,000 | 2,510,000 |
| Gross Profit | 2,048,000 | 1,852,000 | 1,763,000 | 2,063,000 | 1,958,000 |
| Operating Expenses | 6,270,000 | 1,566,000 | 1,591,000 | 1,870,000 | 1,810,000 |
| Operating Income | -4,222,000 | 286,000 | 172,000 | 193,000 | 148,000 |
| Other Income | 4,362,000 | -4,609,000 | -223,000 | -227,000 | -192,000 |
| Pre-tax Income | 140,000 | -4,323,000 | -51,000 | -34,000 | -44,000 |
| Income Tax | -21,000 | 16,000 | -104,000 | -59,000 | -119,000 |
| Net Income Continuous | 161,000 | -4,339,000 | 53,000 | 25,000 | 75,000 |
| Minority Interests | 12,000 | 10,000 | -87,000 | -44,000 | -35,000 |
| Net Income | $151,000 | $-4,350,000 | $140,000 | $69,000 | $110,000 |
| EPS Basic Total Ops | 0.14 | -3.97 | 0.13 | 0.06 | 0.11 |
| EPS Basic Continuous Ops | 0.14 | -3.96 | 0.05 | 0.02 | 0.07 |
| EPS Diluted Total Ops | 0.14 | -3.97 | 0.13 | 0.06 | 0.11 |
| EPS Diluted Continuous Ops | 0.14 | -3.96 | 0.05 | 0.02 | 0.07 |
| EBITDA(a) | $-3,827,000 | $667,000 | $554,000 | $592,000 | $564,000 |